BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21325596)

  • 1. Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions.
    Quentin S; Cuccuini W; Ceccaldi R; Nibourel O; Pondarre C; Pagès MP; Vasquez N; Dubois d'Enghien C; Larghero J; Peffault de Latour R; Rocha V; Dalle JH; Schneider P; Michallet M; Michel G; Baruchel A; Sigaux F; Gluckman E; Leblanc T; Stoppa-Lyonnet D; Preudhomme C; Socié G; Soulier J
    Blood; 2011 Apr; 117(15):e161-70. PubMed ID: 21325596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An uncommon t(9;11)(p24;q22) with monoallelic loss of
    Lovatel VL; de Souza DC; Alvarenga TF; Capela de Matos RR; Diniz C; Schramm MT; Llerena Júnior JC; Silva MLM; Abdelhay E; de Souza Fernandez T
    Mol Cytogenet; 2018; 11():40. PubMed ID: 30008805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric analysis of etoposide exposed mesenchymal stem cells and Fanconi anemia cells: implications in development of secondary myeloid malignancy.
    Özdemir C; Muratoğlu B; Özel BN; Alpdündar-Bulut E; Tonyalı G; Ünal Ş; Uçkan-Çetinkaya D
    Clin Exp Med; 2023 Dec; 23(8):4511-4524. PubMed ID: 37179284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem/stromal cells from a transplanted, asymptomatic patient with Fanconi anemia exhibit an aging-like phenotype and dysregulated expression of genes implicated in hematopoiesis and myelodysplasia.
    Haga CL; Boregowda SV; Booker CN; Krishnappa V; Strivelli J; Cappelli E; Phinney DG
    Cytotherapy; 2023 Apr; 25(4):362-368. PubMed ID: 36481320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shared Copy Number Variation in Simultaneous Nephroblastoma and Neuroblastoma due to Fanconi Anemia.
    Serra A; Eirich K; Winkler AK; Mrasek K; Göhring G; Barbi G; Cario H; Schlegelberger B; Pokora B; Liehr T; Leriche C; Henne-Bruns D; Barth TF; Schindler D
    Mol Syndromol; 2012 Sep; 3(3):120-130. PubMed ID: 23112754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells.
    Ceccaldi R; Parmar K; Mouly E; Delord M; Kim JM; Regairaz M; Pla M; Vasquez N; Zhang QS; Pondarre C; Peffault de Latour R; Gluckman E; Cavazzana-Calvo M; Leblanc T; Larghero J; Grompe M; Socié G; D'Andrea AD; Soulier J
    Cell Stem Cell; 2012 Jul; 11(1):36-49. PubMed ID: 22683204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is wrong with Fanconi anemia cells?
    Cantor SB; Brosh RM
    Cell Cycle; 2014; 13(24):3823-7. PubMed ID: 25486020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical effect of point mutations in myelodysplastic syndromes.
    Bejar R; Stevenson K; Abdel-Wahab O; Galili N; Nilsson B; Garcia-Manero G; Kantarjian H; Raza A; Levine RL; Neuberg D; Ebert BL
    N Engl J Med; 2011 Jun; 364(26):2496-506. PubMed ID: 21714648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fanconi anemia (FA)-associated 3q gains in leukemic transformation consistently target EVI1, but do not affect low TERC expression in FA.
    Meyer S; Bristow C; Wappett M; Pepper S; Whetton AD; Hanenberg H; Neitzel H; Wlodarski MW; Ebell W; Tönnies H
    Blood; 2011 Jun; 117(22):6047-50. PubMed ID: 21636719
    [No Abstract]   [Full Text] [Related]  

  • 10. Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse.
    Clappier E; Gerby B; Sigaux F; Delord M; Touzri F; Hernandez L; Ballerini P; Baruchel A; Pflumio F; Soulier J
    J Exp Med; 2011 Apr; 208(4):653-61. PubMed ID: 21464223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational Spectrum of Fanconi Anemia Associated Myeloid Neoplasms.
    Chao MM; Thomay K; Goehring G; Wlodarski M; Pastor V; Schlegelberger B; Schindler D; Kratz CP; Niemeyer C
    Klin Padiatr; 2017 Nov; 229(6):329-334. PubMed ID: 29132164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How I treat MDS and AML in Fanconi anemia.
    Peffault de Latour R; Soulier J
    Blood; 2016 Jun; 127(24):2971-9. PubMed ID: 27020090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia.
    Sebert M; Gachet S; Leblanc T; Rousseau A; Bluteau O; Kim R; Ben Abdelali R; Sicre de Fontbrune F; Maillard L; Fedronie C; Murigneux V; Bellenger L; Naouar N; Quentin S; Hernandez L; Vasquez N; Da Costa M; Prata PH; Larcher L; de Tersant M; Duchmann M; Raimbault A; Trimoreau F; Fenneteau O; Cuccuini W; Gachard N; Auger N; Tueur G; Blanluet M; Gazin C; Souyri M; Langa Vives F; Mendez-Bermudez A; Lapillonne H; Lengline E; Raffoux E; Fenaux P; Adès L; Forcade E; Jubert C; Domenech C; Strullu M; Bruno B; Buchbinder N; Thomas C; Petit A; Leverger G; Michel G; Cavazzana M; Gluckman E; Bertrand Y; Boissel N; Baruchel A; Dalle JH; Clappier E; Gilson E; Deriano L; Chevret S; Sigaux F; Socié G; Stoppa-Lyonnet D; de Thé H; Antoniewski C; Bluteau D; Peffault de Latour R; Soulier J
    Cell Stem Cell; 2023 Feb; 30(2):153-170.e9. PubMed ID: 36736290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STIM1 translocation to the nucleus protects cells from DNA damage.
    Sanchez-Lopez I; Orantos-Aguilera Y; Pozo-Guisado E; Alvarez-Barrientos A; Lilla S; Zanivan S; Lachaud C; Martin-Romero FJ
    Nucleic Acids Res; 2024 Mar; 52(5):2389-2415. PubMed ID: 38224453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Fanconi anemia beyond childhood.
    Olson TS
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):556-562. PubMed ID: 38066849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EVI1-mediated Programming of Normal and Malignant Hematopoiesis.
    Lux S; Milsom MD
    Hemasphere; 2023 Oct; 7(10):e959. PubMed ID: 37810550
    [No Abstract]   [Full Text] [Related]  

  • 17. FANCA deficiency promotes leukaemic progression by allowing the emergence of cells carrying oncogenic driver mutations.
    Pawlikowska P; Delestré L; Gregoricchio S; Oppezzo A; Esposito M; Diop MB; Rosselli F; Guillouf C
    Oncogene; 2023 Sep; 42(37):2764-2775. PubMed ID: 37573408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clickable melphalan for monitoring DNA interstrand crosslink accumulation and detecting ICL repair defects in Fanconi anemia patient cells.
    Berrada S; Martínez-Balsalobre E; Larcher L; Azzoni V; Vasquez N; Da Costa M; Abel S; Audoly G; Lee L; Montersino C; Castellano R; Combes S; Gelot C; Ceccaldi R; Guervilly JH; Soulier J; Lachaud C
    Nucleic Acids Res; 2023 Aug; 51(15):7988-8004. PubMed ID: 37395445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RUNX1 mutations mitigate quiescence to promote transformation of hematopoietic progenitors in Fanconi anemia.
    Marion W; Koppe T; Chen CC; Wang D; Frenis K; Fierstein S; Sensharma P; Aumais O; Peters M; Ruiz-Torres S; Chihanga T; Boettcher S; Shimamura A; Bauer DE; Schlaeger T; Wells SI; Ebert BL; Starczynowski D; da Rocha EL; Rowe RG
    Leukemia; 2023 Aug; 37(8):1698-1708. PubMed ID: 37391485
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.